Functional polymers based on dextran

被引:250
作者
Heinze, Thomas [1 ]
Liebert, Tim [1 ]
Heublein, Brigitte [1 ]
Hornig, Stephanie [1 ]
机构
[1] Univ Jena, Kompetenzzentrum Polysaccharidforsch, D-07743 Jena, Germany
来源
POLYSACCHARIDES II | 2006年 / 205卷
关键词
functionalised dextran; structural analysis; prodrugs; nanostructures; bioactivity;
D O I
10.1007/12_100
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Dextran, comprising a family of neutral polysaccharides consisting of an alpha-(1 -> 6) linked D-glucose main chain with varying proportions of linkages and branches, depending on the bacteria used, is an interesting starting material for chemical modification reactions for the design of new functional polymers with promising properties. The review summarises recent results on structure characterisation of dextran including some comments on biosynthesis of this important class of biopolymers. Applications of dextran are discussed as well. Chemical modification reactions of dextran are increasingly studied for the structure and hence property design. The review highlights recent progress in esterification of dextran, both inorganic and organic polysaccharide esters, etherification reactions towards ionic and non-ionic ethers, and the huge variety of different conversions mainly developed for the binding of drugs. It summarises recent developments in the application of dextran derivatives with a focus on the chemical structures behind these materials such as prodrugs, bioactivity of inorganic dextran esters, heparin sulfate mimics, hydrogels, nanoparticles and self assembly structures for surface modification.
引用
收藏
页码:199 / 291
页数:93
相关论文
共 397 条
[1]   ORAL DEXTRAN SULFATE (UA001) IN THE TREATMENT OF THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND AIDS-RELATED COMPLEX [J].
ABRAMS, DI ;
KUNO, S ;
WONG, R ;
JEFFORDS, K ;
NASH, M ;
MOLAGHAN, JB ;
GORTER, R ;
UENO, R .
ANNALS OF INTERNAL MEDICINE, 1989, 110 (03) :183-188
[2]  
AEHLE W, 2004, ENZYMES IND PRODUCTI, P62
[3]  
AKASHI M, 2002, ADV CHITIN SCI, V5, P278
[4]  
ALSOP RM, 1977, PROCESS BIOCHEM, V12, P15
[5]  
Andrieu M, 2000, EUR J IMMUNOL, V30, P3256, DOI 10.1002/1521-4141(200011)30:11<3256::AID-IMMU3256>3.0.CO
[6]  
2-H
[7]  
[Anonymous], 1973, Carbohydrate Research
[8]  
[Anonymous], 1998, BIOPOLYMERS RENEWABL, DOI DOI 10.1007/978-3-662-03680-8_2
[9]  
[Anonymous], 2002, Biopolymers
[10]  
[Anonymous], PHARM CHEM J, DOI 10.1023/A